Details for New Drug Application (NDA): 089341
✉ Email this page to a colleague
The generic ingredient in METHOTREXATE SODIUM is calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate profile page.
Summary for 089341
Tradename: | METHOTREXATE SODIUM |
Applicant: | Hikma |
Ingredient: | methotrexate sodium |
Patents: | 0 |
Pharmacology for NDA: 089341
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Suppliers and Packaging for NDA: 089341
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHOTREXATE SODIUM | methotrexate sodium | INJECTABLE;INJECTION | 089341 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9518 | 0143-9518-01 | 1 VIAL in 1 BOX (0143-9518-01) / 4 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 100MG BASE/4ML (EQ 25MG BASE/ML) | ||||
Approval Date: | Sep 16, 1986 | TE: | AP | RLD: | No |
Complete Access Available with Subscription